Olympus Partners has acquired PAI Pharma, a US-based manufacturer of generic oral liquids. No financial terms were disclosed. Kurt Orlofski serves as CEO of PAI. PAI Pharma has two large manufacturing ...

Olympus Partners was recognized for the second consecutive year as a Top 20 performer globally by the 2024 HEC Paris-DowJones Large Buyout Performance Ranking Report. The report names the world's top ...

In a joint, equally-split transaction, the pair of investors have snapped up the Minneapolis-based company from Olympus ...

STAMFORD, Conn., Jan. 2, 2025 /PRNewswire/ -- Olympus Partners is pleased to announce the acquisition of Accelevation, a leading provider of infrastructure products and services to the data center ...